Clinical Trials Browser

Phase 1/2 × Recruiting × capivasertib × Clear all

NCT07287917 2026-03-12

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Phase 1/2 Recruiting

BreastDermatologic

Breast Neoplasms, Melanoma

NCT07294677 2026-03-04

CAVALRY

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms